Tag: Phase 1 trial
Correction Published for ABBV-706 Phase 1 Trial in Small Cell Lung Cancer and Solid Tumors
Nature Medicine has published an author correction to the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate for advanced small…
First Lassa Fever Vaccine Shows Promise in Early Human Trial
First-in-human trial of dual rabies-Lassa fever vaccine shows promising safety and immune response results. The breakthrough could protect millions in…
MAGE-A4/MAGE-A8-Targeted Bispecific T Cell Engager Shows Promise in Refractory Solid Tumors
Novel bispecific T cell engager IMA401 targeting MAGE-A4/MAGE-A8 shows encouraging safety and preliminary efficacy in phase 1a trial. Early results…
Submit Your Paper to GMJ
No APC until January 2027.